Literature DB >> 22157044

Neoadjuvant downsizing by internal radiation: a case for preoperative peptide receptor radionuclide therapy in patients with pancreatic neuroendocrine tumors.

Samer Ezziddin1, Holger Lauschke, Michael Schaefers, Carsten Meyer, Martijn van Essen, Hans-Jürgen Biersack, Dik J Kwekkeboom, Hojjat Ahmadzadehfar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22157044     DOI： 10.1097/RLU.0b013e318238f111

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN： 0363-9762            Impact factor:   7.794


× No keyword cloud information.
  11 in total

1.  The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors.

Authors:  James R Howe; Nipun B Merchant; Claudius Conrad; Xavier M Keutgen; Julie Hallet; Jeffrey A Drebin; Rebecca M Minter; Terry C Lairmore; Jennifer F Tseng; Herbert J Zeh; Steven K Libutti; Gagandeep Singh; Jeffrey E Lee; Thomas A Hope; Michelle K Kim; Yusuf Menda; Thorvardur R Halfdanarson; Jennifer A Chan; Rodney F Pommier
Journal:  Pancreas       Date:  2020-01       Impact factor: 3.327

Review 2.  Radionuclide therapy beyond radioiodine.

Authors:  Michael Gabriel
Journal:  Wien Med Wochenschr       Date:  2012-07-20

Review 3.  Radionuclide Therapy for Neuroendocrine Tumors.

Authors:  Mauro Cives; Jonathan Strosberg
Journal:  Curr Oncol Rep       Date:  2017-02       Impact factor: 5.075

Review 4.  Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature review.

Authors:  Luca Urso; Alberto Nieri; Ilaria Rambaldi; Angelo Castello; Licia Uccelli; Corrado Cittanti; Stefano Panareo; Irene Gagliardi; Maria Rosaria Ambrosio; Maria Chiara Zatelli; Mirco Bartolomei
Journal:  Endocrine       Date:  2022-08-26       Impact factor: 3.925

Review 5.  Peptide receptor radionuclide therapy: focus on bronchial neuroendocrine tumors.

Authors:  Giuseppe Lo Russo; Sara Pusceddu; Natalie Prinzi; Martina Imbimbo; Claudia Proto; Diego Signorelli; Milena Vitali; Monica Ganzinelli; Marco Maccauro; Roberto Buzzoni; Ettore Seregni; Filippo de Braud; Marina Chiara Garassino
Journal:  Tumour Biol       Date:  2016-07-27

6.  Role of 18FDG PET/CT in patients treated with 177Lu-DOTATATE for advanced differentiated neuroendocrine tumours.

Authors:  Stefano Severi; Oriana Nanni; Lisa Bodei; Maddalena Sansovini; Annarita Ianniello; Stefania Nicoletti; Emanuela Scarpi; Federica Matteucci; Laura Gilardi; Giovanni Paganelli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-02-27       Impact factor: 9.236

Review 7.  Targeted radionuclide therapies for pancreatic cancer.

Authors:  M Shah; R Da Silva; C Gravekamp; S K Libutti; T Abraham; E Dadachova
Journal:  Cancer Gene Ther       Date:  2015-07-31       Impact factor: 5.987

Review 8.  Peptide Receptor Radionuclide Therapy and the Treatment of Gastroentero-pancreatic Neuroendocrine Tumors: Current Findings and Future Perspectives.

Authors:  Nader Hirmas; Raya Jadaan; Akram Al-Ibraheem
Journal:  Nucl Med Mol Imaging       Date:  2018-03-28

9.  Position Statement on the Diagnosis, Treatment, and Response Evaluation to Systemic Therapies of Advanced Neuroendocrine Tumors, With a Special Focus on Radioligand Therapy.

Authors:  Jaume Capdevila; Enrique Grande; Rocío García-Carbonero; Marc Simó; Mª Isabel Del Olmo-García; Paula Jiménez-Fonseca; Alberto Carmona-Bayonas; Virginia Pubul
Journal:  Oncologist       Date:  2022-04-05

Review 10.  Neoadjuvant Therapy for Neuroendocrine Neoplasms: Recent Progresses and Future Approaches.

Authors:  Andrea Lania; Francesco Ferraù; Manila Rubino; Roberta Modica; Annamaria Colao; Antongiulio Faggiano
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-26       Impact factor: 5.555
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.